APA (7th ed.) Citation

Li, J., Ding, F., Zhang, S., Jia, Y., Zhang, T., Wang, S., . . . Guo, Z. (2024). Continuation of same programmed death-1 inhibitor regime beyond progression is a novel option for advanced gastric cancer. BMC Cancer, 24(1), 1. https://doi.org/10.1186/s12885-024-13063-2

Chicago Style (17th ed.) Citation

Li, Jiasong, Fang Ding, Shasha Zhang, Yuanyuan Jia, Tianhang Zhang, Siqi Wang, Qingyi Liu, and Zhanjun Guo. "Continuation of Same Programmed Death-1 Inhibitor Regime Beyond Progression Is a Novel Option for Advanced Gastric Cancer." BMC Cancer 24, no. 1 (2024): 1. https://doi.org/10.1186/s12885-024-13063-2.

MLA (9th ed.) Citation

Li, Jiasong, et al. "Continuation of Same Programmed Death-1 Inhibitor Regime Beyond Progression Is a Novel Option for Advanced Gastric Cancer." BMC Cancer, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12885-024-13063-2.